Yagi et al. [7] conducted a randomized controlled trial on patients with essential hypertension to investigate whether plasma aldosterone level is associated with cognitive impairment and whether MR blockade alleviates cognitive dysfunction in hypertensive patients. The gene discussed is NR3C2; the disease is essential hypertension.